Approximately Half of Americans Surveyed Notice the Eyes First, Supporting the Mission of the Campaign to Empower Chronic Dry Eye Sufferers to Take Action DUBLIN, May 16, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced the results of a new online eye language survey of 1,019 adult Americans that found approximately half of respondents […]
DUBLIN, May 4, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company in women’s healthcare, will present new data from its women’s healthcare portfolio, at the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting in San Diego, May 6-9. The scheduled times (noted in local Pacific Time) […]
Acquisition Adds Best-in-Class Body Contouring Business to Allergan’s World-Class Facial Aesthetics, Plastic Surgery & Regenerative Medicine Businesses Acquisition of CoolSculpting,® Sales Leader in Fast-Growing, Cash Pay Body Contouring Segment, is Immediately Accretive to Allergan DUBLIN, April 28, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced it has successfully completed […]
First-of-its-Kind Product Further Adds to Allergan’s Robust Eye Care Portfolio DUBLIN, April 25, 2017 /PRNewswire/ — Allergan plc, (NYSE: AGN) today announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear™ Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during […]
Five-Year Study to Enroll 15,000 Adults and Children with NAFLD or NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 20, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, […]
DUBLIN, April 20, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has 13 presentations at the upcoming 69th American Academy of Neurology (AAN) annual meeting taking place April 22-28, 2017 in Boston. Among the highlights are three podium presentations on Chronic Migraine disease awareness and post-stroke spasticity […]
Collaboration Focused on Phase 2b Clinical Trial to Evaluate Use of Allergan’s Cenicriviroc (CVC) and Novartis Lead FXR Agonist to Treat NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 18, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it has entered into a […]
TV Host Wendy Williams Leads the Conversation on the Importance of Bowel Health at the “Vital Signs of Bowel Health” Summit DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ — Allergan plc (NYSE:AGN) and Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), in partnership with the American Gastroenterological Association (AGA), initiated a campaign about the importance of bowel health in recognition […]
Campaign educates on the debilitating impact of migraine on patients’ everyday lives DUBLIN, April 11, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today unveiled Frames of Mind, an interactive campaign to promote awareness of the impact that migraine can have on patients’ everyday lives. People living with this often debilitating condition are encouraged to submit […]
Company Recognized with ENERGY STAR Award for Sixth Time DUBLIN, April 10, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced that it has been named a 2017 ENERGY STAR Partner of the Year – Sustained Excellence Award winner. The Company has been recognized for continued leadership in protecting the environment through superior energy efficiency […]